The use of sodium-glucose transporter (SGLT-2) inhibitors can reduce the progression of chornic kidney disease in diabetics and non-diabetics
The use of sodium-glucose transporter (SGLT-2) inhibitors can reduce the progression of chornic kidney disease in diabetics and non-diabetics